Go Pro
Guggenheim

Guggenheim Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Guggenheim. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Guggenheim's equity research team. MarketBeat is not affiliated with or endorsed by Guggenheim.

Average Return
00.00% 12-Month ROI
Total Ratings
1,014 Last 12 Months
Buy Ratings
854 Last 12 Months
Sell Ratings
9 Last 12 Months
Companies Covered
379 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
ANI Pharmaceuticals, Inc. stock logo
ANIP
ANI Pharmaceuticals
$82.07
-2.0%
7/10/2026Reiterated Rating$124.00BuyView details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 7/10/2026
Insmed, Inc. stock logo
INSM
Insmed
$115.61
-2.2%
7/10/2026Reiterated Rating$207.00BuyView details for Guggenheim rating of Insmed (NASDAQ:INSM) on 7/10/2026
LGN stock logo
LGN
LGN
$73.66
-0.4%
7/10/2026Boost Price Target$106.00 ➝ $115.00BuyView details for Guggenheim rating of LGN (NASDAQ:LGN) on 7/10/2026
AbbVie Inc. stock logo
ABBV
AbbVie
$248.00
-0.8%
7/9/2026Boost Price Target$249.00 ➝ $261.00BuyView details for Guggenheim rating of AbbVie (NYSE:ABBV) on 7/9/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$186.88
-2.2%
7/9/2026Boost Price Target$205.00 ➝ $235.00BuyView details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 7/9/2026
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$42.00
-1.1%
7/8/2026Boost Price Target$56.00 ➝ $76.00BuyView details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 7/8/2026
Waters Corporation stock logo
WAT
Waters
$377.35
+0.1%
7/8/2026Reiterated Rating$440.00BuyView details for Guggenheim rating of Waters (NYSE:WAT) on 7/8/2026
SharkNinja, Inc. stock logo
SN
SharkNinja
$152.62
+2.6%
7/6/2026Boost Price Target$145.00 ➝ $175.00BuyView details for Guggenheim rating of SharkNinja (NYSE:SN) on 7/6/2026
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
$45.41
-6.1%
7/6/2026Boost Price Target$41.00 ➝ $51.00BuyView details for Guggenheim rating of Edgewise Therapeutics (NASDAQ:EWTX) on 7/6/2026
Parabilis Medicines, Inc. stock logo
PBLS
Parabilis Medicines
$30.57
+0.7%
7/6/2026Initiated Coverage$40.00BuyView details for Guggenheim rating of Parabilis Medicines (NASDAQ:PBLS) on 7/6/2026
Parabilis Medicines, Inc. stock logo
PBLS
Parabilis Medicines
$30.57
+0.7%
7/6/2026Initiated Coverage$40.00BuyView details for Guggenheim rating of Parabilis Medicines (NASDAQ:PBLS) on 7/6/2026
Cinemark Holdings Inc stock logo
CNK
Cinemark
$29.01
-2.0%
7/2/2026 Set Price Target$37.00View details for Guggenheim rating of Cinemark (NYSE:CNK) on 7/2/2026
The Kroger Co. stock logo
KR
Kroger
$60.58
+1.2%
7/2/2026Reiterated Rating$71.00BuyView details for Guggenheim rating of Kroger (NYSE:KR) on 7/2/2026
Septerna, Inc. stock logo
SEPN
Septerna
$35.93
-5.0%
7/1/2026Lower Price Target$52.00 ➝ $45.00BuyView details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 7/1/2026
Check Point Software Technologies Ltd. stock logo
CHKP
Check Point Software Technologies
$131.70
-4.7%
7/1/2026Upgrade$188.00NeutralBuyView details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 7/1/2026
ServiceNow, Inc. stock logo
NOW
ServiceNow
$107.81
-0.9%
7/1/2026Upgrade$125.00NeutralBuyView details for Guggenheim rating of ServiceNow (NYSE:NOW) on 7/1/2026
Salesforce Inc. stock logo
CRM
Salesforce
$163.34
+0.5%
7/1/2026Upgrade$228.00NeutralBuyView details for Guggenheim rating of Salesforce (NYSE:CRM) on 7/1/2026
NIKE, Inc. stock logo
NKE
NIKE
$44.39
+3.8%
7/1/2026Reiterated Rating$74.00 ➝ $60.00BuyView details for Guggenheim rating of NIKE (NYSE:NKE) on 7/1/2026
Progress Software Corporation stock logo
PRGS
Progress Software
$37.86
-1.7%
7/1/2026Reiterated Rating$83.00BuyView details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 7/1/2026
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$23.04
-6.0%
6/30/2026Boost Price Target$30.00 ➝ $35.00BuyView details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 6/30/2026
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$23.04
-6.0%
6/30/2026Boost Price Target$30.00 ➝ $35.00BuyView details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 6/30/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$139.90
-0.6%
6/30/2026 Reiterated RatingBuyView details for Guggenheim rating of Abivax (NASDAQ:ABVX) on 6/30/2026
Tesla, Inc. stock logo
TSLA
Tesla
$407.76
+0.3%
6/29/2026 Initiated CoverageSellNeutralView details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 6/29/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$65.64
-5.4%
6/29/2026Reiterated Rating$70.00 ➝ $74.00BuyView details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 6/29/2026
Veracyte, Inc. stock logo
VCYT
Veracyte
$56.97
-3.9%
6/29/2026Boost Price Target$45.00 ➝ $65.00BuyView details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 6/29/2026
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$90.64
-3.2%
6/29/2026Boost Price Target$60.00 ➝ $107.00BuyView details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 6/29/2026
Natera, Inc. stock logo
NTRA
Natera
$269.95
-4.2%
6/29/2026Boost Price Target$270.00 ➝ $290.00BuyView details for Guggenheim rating of Natera (NASDAQ:NTRA) on 6/29/2026
Illumina, Inc. stock logo
ILMN
Illumina
$190.20
-1.8%
6/29/2026Boost Price Target$180.00 ➝ $200.00BuyView details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 6/29/2026
Guardant Health, Inc. stock logo
GH
Guardant Health
$160.05
-2.5%
6/29/2026Boost Price Target$135.00 ➝ $160.00BuyView details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 6/29/2026
Bruker Corporation stock logo
BRKR
Bruker
$60.06
-0.9%
6/29/2026Boost Price Target$50.00 ➝ $70.00BuyView details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 6/29/2026
Billiontoone, Inc. stock logo
BLLN
Billiontoone
$126.77
-0.9%
6/29/2026Initiated Coverage$120.00 ➝ $125.00BuyView details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 6/29/2026
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$21.06
-3.4%
6/29/2026Boost Price Target$21.00 ➝ $22.00BuyView details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 6/29/2026
The Home Depot, Inc. stock logo
HD
Home Depot
$343.45
+1.4%
6/29/2026Reiterated RatingBuyView details for Guggenheim rating of Home Depot (NYSE:HD) on 6/29/2026
Performance Food Group Company stock logo
PFGC
Performance Food Group
$113.31
+1.1%
6/29/2026Boost Price Target$115.00 ➝ $125.00BuyView details for Guggenheim rating of Performance Food Group (NYSE:PFGC) on 6/29/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$257.17
-0.7%
6/26/2026Boost Price Target$266.00 ➝ $270.00BuyView details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 6/26/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$56.59
-3.2%
6/25/2026Boost Price Target$56.00 ➝ $65.00BuyView details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 6/25/2026
Oklo Inc. stock logo
OKLO
Oklo
$48.84
-0.9%
6/25/2026Initiated CoverageNeutralView details for Guggenheim rating of Oklo (NYSE:OKLO) on 6/25/2026
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$17.77
-3.3%
6/25/2026Boost Price Target$30.00 ➝ $40.00BuyView details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 6/25/2026
DraftKings Inc. stock logo
DKNG
DraftKings
$26.48
+0.7%
6/24/2026Reiterated Rating$35.00BuyView details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 6/24/2026
Darden Restaurants, Inc. stock logo
DRI
Darden Restaurants
$204.21
+1.1%
6/24/2026Boost Price Target$230.00 ➝ $235.00BuyView details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 6/24/2026
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$14.72
-0.8%
6/24/2026Reiterated Rating$68.00BuyView details for Guggenheim rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 6/24/2026
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
$133.65
+0.1%
6/23/2026DowngradeBuyNeutralView details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 6/23/2026
DoorDash, Inc. stock logo
DASH
DoorDash
$191.82
-0.3%
6/23/2026Reiterated Rating$255.00BuyView details for Guggenheim rating of DoorDash (NASDAQ:DASH) on 6/23/2026
Primoris Services Corporation stock logo
PRIM
Primoris Services
$86.73
-3.0%
6/23/2026Reiterated Rating$162.00BuyView details for Guggenheim rating of Primoris Services (NYSE:PRIM) on 6/23/2026
The Kroger Co. stock logo
KR
Kroger
$60.58
+1.2%
6/22/2026Set Price Target$78.00 ➝ $71.00BuyView details for Guggenheim rating of Kroger (NYSE:KR) on 6/22/2026
Accenture PLC stock logo
ACN
Accenture
$135.19
-2.8%
6/22/2026Lower Price Target$225.00 ➝ $185.00BuyView details for Guggenheim rating of Accenture (NYSE:ACN) on 6/22/2026
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
$17.55
-4.2%
6/22/2026Reiterated Rating$34.00 ➝ $40.00BuyView details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 6/22/2026
Accenture PLC stock logo
ACN
Accenture
$135.19
-2.8%
6/22/2026Lower Price Target$225.00 ➝ $185.00BuyView details for Guggenheim rating of Accenture (NYSE:ACN) on 6/22/2026
The Kroger Co. stock logo
KR
Kroger
$60.58
+1.2%
6/22/2026Reiterated Rating$78.00 ➝ $71.00BuyView details for Guggenheim rating of Kroger (NYSE:KR) on 6/22/2026
Qualcomm Incorporated stock logo
QCOM
Qualcomm
$189.16
-1.0%
6/22/2026 Set Price Target$200.00View details for Guggenheim rating of Qualcomm (NASDAQ:QCOM) on 6/22/2026
Sirius XM Holdings Inc. stock logo
SIRI
Sirius XM
$30.42
-0.9%
6/17/2026Reiterated RatingBuyView details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 6/17/2026
Via Transportation Inc. stock logo
VIA
Via Transportation
$17.98
-1.8%
6/17/2026 Reiterated Rating$50.00BuyView details for Guggenheim rating of Via Transportation (NYSE:VIA) on 6/17/2026
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$50.07
-3.2%
6/16/2026Initiated Coverage$123.00BuyView details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 6/16/2026
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$50.07
-3.2%
6/16/2026Initiated Coverage$123.00BuyView details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 6/16/2026
Pinterest, Inc. stock logo
PINS
Pinterest
$22.53
-0.7%
6/15/2026Reiterated Rating$24.00BuyView details for Guggenheim rating of Pinterest (NYSE:PINS) on 6/15/2026
Life Time Group Holdings, Inc. stock logo
LTH
Life Time Group
$41.85
+0.4%
6/15/2026Boost Price Target$36.00 ➝ $41.00BuyView details for Guggenheim rating of Life Time Group (NYSE:LTH) on 6/15/2026
Absci Corporation stock logo
ABSI
Absci
$10.60
-7.6%
6/15/2026Boost Price Target$10.00 ➝ $15.00BuyView details for Guggenheim rating of Absci (NASDAQ:ABSI) on 6/15/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
$4.75
-7.4%
6/15/2026Boost Price Target$6.00 ➝ $11.00BuyView details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 6/15/2026
Target Corporation stock logo
TGT
Target
$134.94
+2.0%
6/12/2026Boost Price Target$140.00 ➝ $145.00BuyView details for Guggenheim rating of Target (NYSE:TGT) on 6/12/2026
STUB stock logo
STUB
STUB
$11.13
-3.4%
6/12/2026Reiterated RatingBuyView details for Guggenheim rating of STUB (NYSE:STUB) on 6/12/2026
RH stock logo
RH
RH
$165.20
-1.9%
6/12/2026Reiterated Rating$200.00BuyView details for Guggenheim rating of RH (NYSE:RH) on 6/12/2026
Septerna, Inc. stock logo
SEPN
Septerna
$35.93
-5.0%
6/11/2026 Initiated Coverage$52.00BuyView details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 6/11/2026
Accenture PLC stock logo
ACN
Accenture
$135.19
-2.8%
6/11/2026Lower Price Target$250.00 ➝ $225.00BuyView details for Guggenheim rating of Accenture (NYSE:ACN) on 6/11/2026
Oracle Corporation stock logo
ORCL
Oracle
$140.69
-2.4%
6/11/2026Reiterated Rating$400.00BuyView details for Guggenheim rating of Oracle (NYSE:ORCL) on 6/11/2026
Septerna, Inc. stock logo
SEPN
Septerna
$35.93
-5.0%
6/11/2026 UpgradeStrong-BuyView details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 6/11/2026
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$97.60
-2.4%
6/10/2026 Reiterated RatingBuyView details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 6/10/2026
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$13.35
-4.2%
6/10/2026Boost Price Target$25.00 ➝ $29.00BuyView details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 6/10/2026
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$123.90
+0.1%
6/10/2026Downgrade$151.00 ➝ $124.00BuyNeutralView details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 6/10/2026
Cloudflare, Inc. stock logo
NET
Cloudflare
$268.46
-2.7%
6/10/2026Reiterated Rating$140.00SellView details for Guggenheim rating of Cloudflare (NYSE:NET) on 6/10/2026
Lyft, Inc. stock logo
LYFT
Lyft
$15.61
-0.8%
6/10/2026 Reiterated RatingBuyView details for Guggenheim rating of Lyft (NASDAQ:LYFT) on 6/10/2026
Passage Bio, Inc. stock logo
PASG
Passage Bio
$4.57
-3.0%
6/10/2026 DowngradeBuyNeutralView details for Guggenheim rating of Passage Bio (NASDAQ:PASG) on 6/10/2026
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
$13.42
-0.4%
6/10/2026 DowngradeBuyNeutralView details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 6/10/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$139.27
-5.3%
6/10/2026Reiterated Rating$214.00BuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 6/10/2026
Uber Technologies, Inc. stock logo
UBER
Uber Technologies
$74.56
+0.3%
6/9/2026Reiterated RatingBuyView details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 6/9/2026
Roku, Inc. stock logo
ROKU
Roku
$140.69
+0.3%
6/9/2026Boost Price Target$140.00 ➝ $145.00BuyView details for Guggenheim rating of Roku (NASDAQ:ROKU) on 6/9/2026
Entrada Therapeutics, Inc. stock logo
TRDA
Entrada Therapeutics
$6.92
-6.5%
6/8/2026Lower Price Target$20.00 ➝ $17.00BuyView details for Guggenheim rating of Entrada Therapeutics (NASDAQ:TRDA) on 6/8/2026
Five Below, Inc. stock logo
FIVE
Five Below
$189.39
+2.8%
6/8/2026Lower Price Target$260.00 ➝ $250.00BuyView details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 6/8/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$14.00
+1.3%
6/8/2026Initiated Coverage$35.00BuyView details for Guggenheim rating of Climb Bio (NASDAQ:CLYM) on 6/8/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$14.00
+1.3%
6/8/2026Initiated Coverage$35.00BuyView details for Guggenheim rating of Climb Bio (NASDAQ:CLYM) on 6/8/2026
Fervo Energy Company stock logo
FRVO
Fervo Energy
$27.13
-0.8%
6/8/2026Upgrade$48.00Strong-BuyView details for Guggenheim rating of Fervo Energy (NASDAQ:FRVO) on 6/8/2026
Fervo Energy Company stock logo
FRVO
Fervo Energy
$27.13
-0.8%
6/7/2026 Initiated Coverage$48.00BuyView details for Guggenheim rating of Fervo Energy (NASDAQ:FRVO) on 6/7/2026
Oracle Corporation stock logo
ORCL
Oracle
$140.69
-2.4%
6/5/2026Reiterated RatingBuyView details for Guggenheim rating of Oracle (NYSE:ORCL) on 6/5/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
$84.23
-5.1%
6/5/2026Reiterated RatingBuyView details for Guggenheim rating of Rubrik (NYSE:RBRK) on 6/5/2026
Tractor Supply Company stock logo
TSCO
Tractor Supply
$30.43
+1.0%
6/5/2026Reiterated Rating$60.00 ➝ $50.00BuyView details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 6/5/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.92
-2.5%
6/4/2026Initiated Coverage$16.00BuyView details for Guggenheim rating of Opus Genetics (NASDAQ:IRD) on 6/4/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.92
-2.5%
6/4/2026Initiated Coverage$16.00BuyView details for Guggenheim rating of Opus Genetics (NASDAQ:IRD) on 6/4/2026
Celcuity, Inc. stock logo
CELC
Celcuity
$107.58
-5.2%
6/3/2026Reiterated RatingBuyView details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 6/3/2026
GitLab Inc. stock logo
GTLB
GitLab
$32.42
-4.3%
6/3/2026Reiterated RatingNeutralView details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 6/3/2026
Dollar General Corporation stock logo
DG
Dollar General
$118.91
+2.7%
6/3/2026Lower Price Target$160.00 ➝ $140.00BuyView details for Guggenheim rating of Dollar General (NYSE:DG) on 6/3/2026
Yesway, Inc. stock logo
YSWY
Yesway
$20.38
-0.1%
6/3/2026Reiterated RatingBuyView details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 6/3/2026
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

The Madison Square Garden Company stock logo
MSGS
Madison Square Garden
$381.85
-1.4%
6/2/2026Boost Price Target$422.00 ➝ $470.00BuyView details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 6/2/2026
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$20.95
-6.8%
6/2/2026Reiterated Rating$47.00BuyView details for Guggenheim rating of Jade Biosciences (NASDAQ:JBIO) on 6/2/2026
Dell Technologies Inc. stock logo
DELL
Dell Technologies
$435.14
-3.3%
6/1/2026 UpgradeBuyView details for Guggenheim rating of Dell Technologies (NYSE:DELL) on 6/1/2026
Costco Wholesale Corporation stock logo
COST
Costco Wholesale
$916.25
+0.4%
6/1/2026 Reiterated RatingNeutralView details for Guggenheim rating of Costco Wholesale (NASDAQ:COST) on 6/1/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$139.27
-5.3%
6/1/2026Upgrade$214.00NeutralBuyView details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 6/1/2026
Illumina, Inc. stock logo
ILMN
Illumina
$190.20
-1.8%
6/1/2026Boost Price Target$170.00 ➝ $180.00BuyView details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 6/1/2026
Oculis Holding AG stock logo
OCS
Oculis
$13.63
-0.5%
6/1/2026Lower Price Target$75.00 ➝ $45.00BuyView details for Guggenheim rating of Oculis (NASDAQ:OCS) on 6/1/2026
Dollar Tree, Inc. stock logo
DLTR
Dollar Tree
$124.91
+3.3%
5/29/2026Boost Price Target$130.00 ➝ $135.00BuyView details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 5/29/2026
Best Buy Co., Inc. stock logo
BBY
Best Buy
$82.97
+3.7%
5/29/2026Reiterated Rating$90.00BuyView details for Guggenheim rating of Best Buy (NYSE:BBY) on 5/29/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$342.08
-5.7%
5/29/2026Reiterated Rating$475.00BuyView details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 5/29/2026

MarketBeat's community ratings are surveys of what our community members think about Guggenheim and other research firms in the last 90 days. Vote "Outperform" if you believe Guggenheim's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Guggenheim's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
3.0out of 5 (last 90 days)
3 of 5 stars
OUTPERFORM VOTES
3 Believe will outperform the market
UNDERPERFORM VOTES
2 Believe will underperform the market

Guggenheim's equity research team has issued ratings on 372 companies across 16 sectors over the past 12 months, covered by 34 analysts. The Guggenheim analysts below are listed by number of ratings issued in the last year.

Guggenheim Stock Coverage by Sector

Guggenheim concentrates its research most heavily in Medical (46.2%), Computer and Technology (15.3%) and Retail/Wholesale (13.7%). The chart below shows how Guggenheim's 379 rated companies are distributed across all 16 sectors it covers.

Guggenheim - Frequently Asked Questions

Guggenheim's analysts currently have buy-equivalent ratings on 320 companies. Recent upgrades to buy include Check Point Software Technologies, ServiceNow, Salesforce, Septerna and Fervo Energy.

Guggenheim's highest-rated analysts by MarketBeat's accuracy score include Seamus Fernandez, Vamil Divan and Joseph Osha. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 35 analysts at Guggenheim.

Guggenheim has the deepest coverage in Medical (46.2% of rated companies), Computer and Technology (15.3% of rated companies), Retail/Wholesale (13.7% of rated companies), Consumer Discretionary (11.1% of rated companies) and Energy (3.2% of rated companies).

Guggenheim issued 1,014 ratings over the last 12 months across 379 companies — an average of roughly 84 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Guggenheim analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Guggenheim uses Buy, Neutral, and Sell as their equivalents.